-
3 Finished Dosage Generics, Anti-Retroviral and Active Ingredient Leader and Complex Oncology Generics Stocks With a Strong Future Roadmap: Strides Pharma Science, Laurus Labs and Natco Pharma
- October 23, 2026
- Posted by: Kunal Singla
- Category: Best Stocks
No Comments
US Generics and Complex Oncology Drug Stocks with a strong future roadmap: Strides Pharma Science, Laurus Labs and Natco Pharma. Compare price, valuation, return on equity and revenue growth as of 22 October 2026.
-
3 Oncology Generics, Acute Therapy Franchise and Pain and Anti-Malarial Brands Stocks With a Strong Future Roadmap: Natco Pharma, Alkem Laboratories and Ipca Laboratories
- October 22, 2026
- Posted by: Chaitanya Auti
- Category: Best Stocks
Complex Generic and Pain Care Stocks with a strong future roadmap: Natco Pharma, Alkem Laboratories and Ipca Laboratories. Compare price, valuation, return on equity and revenue growth as of 21 October 2026.
-
3 Oncology Generics, Branded Generics and Biologics Platform Stocks With a Strong Future Roadmap: Natco Pharma, Emcure Pharmaceuticals and Shilpa Medicare
- October 21, 2026
- Posted by: Kunal Singla
- Category: Best Stocks
Specialty Generics and Oncology Stocks with a strong future roadmap: Natco Pharma, Emcure Pharmaceuticals and Shilpa Medicare. Compare price, valuation, return on equity and revenue growth as of 20 October 2026.
-
3 Ophthalmic Brands, Cancer Generics and Pharma Excipients Stocks With a Strong Future Roadmap: Ajanta Pharma, Natco Pharma and Sudeep Pharma
- October 21, 2026
- Posted by: Chaitanya Auti
- Category: Best Stocks
Oncology and Excipient Pharma Stocks with a strong future roadmap: Ajanta Pharma, Natco Pharma and Sudeep Pharma. Compare price, valuation, return on equity and revenue growth as of 20 October 2026.
- 1
- 2